Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activitysort descending Investigator Unit Sponsor Date
Technical Study: Analytical Performance Evaluation of Cobas Plus Contract $553,527.00 Clinical Trial Ryan Matika Anesthesiology Roche Diagnostics Operations, Inc. 10/2020
A Phase 3, Randomized, Double- Blinded, Placebo-Controlled Trial To Evaluate the Efficacy and Safety of a Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Infants Born to.... Contract $124,499.00 Clinical Trial Mohamed Ahmed Pediatrics Pfizer, Incorporated 05/2020
A Randomized, Double-Blind, Placebo-controlled, Single-ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of JK07 in Subjects with Heart Failure with Reduced Ejection Fra... Contract $606,162.95 Clinical Trial Nancy Sweitzer Sarver Heart Center Salubris Biotherapeutics 01/2021
Noninterventional Epigenomic Mapping of CD34+ Cells From Healthy Participants and Patients With Myelofibrosis (MF) and Polycythemia Vera (PV) Contract $74,529.50 Clinical Trial Krisstina Gowin Cancer Center Division Incyte Corporation 12/2020
Serum Protein-Based Indices for the Progression of Fracture Healing and Nonunion Contract $42,700.00 Clinical Trial Jason Lowe Orthopedic Surgery Johns Hopkins University 02/2022
Study Using Negative Pressure to Reduce Apnea (SUPRA) Contract $166,386.00 Clinical Trial Sairam Parthasarathy Medicine Sommetrics, Inc 01/2022
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 with Placebo and with Tofacitinib in Combination with Conventional Synthetic DMARDs.... Contract $314,050.00 Clinical Trial Chian Kwoh Arthritis Center-Research IQVIA RDS Inc. 03/2020
Invasive Cardiopulmonary Exercise Testing to Phenotype Post Pulmonary Embolism Dyspnea Contract $99,577.00 Clinical Trial Michael Insel Medicine Bayer Healthcare Pharmaceuticals Incorporated 11/2020
Expanded Access Program Basis for the Treatment of Relapsed/Refractory Multiple Myeloma Contract $95,540.64 Clinical Trial Krisstina Gowin Cancer Center Division Glaxosmithkline 06/2020
COVID-19-C3PO: Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) Contract $1,222,500.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine University of Michigan 08/2020
A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitals Adults with COVID-19 Contract $178,900.00 Clinical Trial Bellal Joseph Surgery New York University 04/2021
The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (PROACTIVE) Study Contract $42,133.70 Clinical Trial Venkatesh Ariyamuthu Medicine Natera, Inc. 10/2020
A Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of FOLFIRINOX (FFX) versus Combination of CPI-613 with modified FOLFIRINOX (mFFX) in Patients with Metastatic... Contract $297,912.00 Clinical Trial Rachna Shroff Cancer Center Division Covance, Incorporated 05/2020
FEnofibRate as a Metabolic INtervention for Coronavirus Disease 2019 (COVID-19): A Randomized Controlled Trial (FERMIN trial) Contract $5,450.00 Clinical Trial Nancy Sweitzer Medicine University of Pennsylvania 01/2021
PETAL Network International Coordinating Center for ACTIV-3 Trial Initiative Grant $820,500.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Albert Einstein College of Medicine 12/2020
A Multicenter, Double-Blind, Multidose, Placebo-Controlled, Randomized, Parallel-Group, Phase 2 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 for Patients with Brain Contusion Contract $96,267.00 Clinical Trial Bellal Joseph Surgery Biogen Incorporated 03/2020
RELIEVE-HF: REducing Lung CongestIon Symptoms Using the V-WavE Shunt in adVancEd Heart Failure Contract $621,878.00 Clinical Trial Nancy Sweitzer Sarver Heart Center V-Wave Ltd. 11/2020
PRECISE: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization Contract $54,987.52 Clinical Trial Michael Morris COM Phx Radiology HeartFlow, Inc. 06/2020
CREON (Pancrelipase) Therapy for Subjects with Exocrine Pancreatic Insufficiency (EPI) due to Pancreatic Cancer: A Double-Blind, Randomized, Parallel Design with 2 Dose Cohorts of Pancrelipase... Contract $117,787.55 Clinical Trial Jen-Jung Pan COM Phx Internal Medicine AbbVie Incorporated 08/2020
A Multicenter, Randomized, Placebo-Controlled, Pragmatic Phase 3 Study Investigating the Efficacy and Safety of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospital Contract $372,615.00 Clinical Trial Monica Kraft Medicine Janssen Research & Development, LLC 04/2021
A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic Adenocarcinoma (TRYbeCA-1 - TRial of ErYaspase Contract $664,687.53 Clinical Trial Hani Babiker Cancer Center Division PPD Investigator Services, LLC. 05/2020
Nitric Oxide Treatment In COVID-19 Evaluation (NOTICE) Contract $18,455.00 Clinical Trial Thomas Ardiles COM Phx Internal Medicine Pharmerit International 01/2021
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects with Heart Failure with Reduced Ejection Fraction... Contract $105,851.40 Clinical Trial Aaron Wolfson Sarver Heart Center Cytokinetics, Incorporated 09/2020
A 16-week Randomized Evaluation of the Impact of Mind.Px Application on Response to Biologic Treatment in Patients Suffering from Plaque Psoriasis Through Clinical Utility and Health Outcomes. (MATCH Contract $82,003.00 Clinical Trial Jawad Bilal Arthritis Center-Research Mindera Corporation 05/2022
A Phase 1/2 Study of ZN-c3 as a Single Agent in Combination with Talazoparib or Pembrolizumab in Patients with Solid Tumors Contract $138,409.52 Clinical Trial Pavani Chalasani Cancer Center Division K-Group Beta, Inc. 03/2020

Pages